DALLAS - TelAve -- Filos Health Laboratory and Filos Health Mobile Blood Collection, a CLIA- and COLA-accredited clinical diagnostics and mobile blood company specializing in precision laboratory testing and AI-powered clinical intelligence, announced today that it will attend JPMorgan Healthcare Week 2026 in San Francisco.

During JPM Health Week, Filos Health will engage with healthcare investors, health system leaders, biopharma partners, and innovators to discuss its mission to transform clinical diagnostics by moving beyond static lab results toward predictive, longitudinal insights that improve patient outcomes.

Filos Health integrates high-quality clinical laboratory testing with advanced artificial intelligence to analyze longitudinal lab data and predict clinical outcomes at 6-month and 12-month horizons. The company currently serves tens of thousands of patients annually across Texas and California, supporting physicians, health systems, and enterprise partners with scalable diagnostic and mobile phlebotomy solutions.

More on TelAve News

• Rande Vick Introduces Radical Value, Challenging How Brands Measure Long-Term Value
• Lisa Mauretti Launches Peace of Mind Travel Coaching to Guide Fearful Travelers to Discover the World with Confidence
• New Year, New Home: Begin 2026 at Heritage at South Brunswick
• Food Journal Magazine Releases Its 'Best Food In Los Angeles Dining' Editorial Section
• Enders Capital: 25% Gains with Just -0.80% Maximum Monthly Drawdown in Volatile Debut Year 2025

"Healthcare generates vast amounts of laboratory data, yet most of it remains underutilized," said Nida Fatima, MD, Founder and CEO of Filos Health Laboratory. "At Filos Health, we believe lab data should not just report the past—it should help predict the future. JPM Healthcare Week provides an important forum to share how we are building the clinical operating system for human biology."

Filos Health is actively engaging with strategic partners and investors aligned with its vision to modernize clinical diagnostics, improve care delivery, and enable data-driven precision medicine at scale.

About Filos Health Laboratory
Filos Health Laboratory is a women-owned, CLIA- and COLA-accredited clinical diagnostics company delivering precision laboratory testing, mobile phlebotomy services, and AI-powered clinical intelligence. Founded in 2018, the company serves patients and providers across Texas and California, with a mission to turn laboratory data into actionable insights that improve health outcomes.

Learn more about clinical diagnostic company: https://www.filoshealthlab.ocm
Learn more about mobile blood collection: https://www.filoshealth.com